IL2 and neoplasm: This enhancement is further characterized by increased production of interferon-gamma (IFN-γ) and interleukin-2 (IL-2) within the TME, concurrent with downregulation of tumor necrosis factor-alpha (TNF-α) and interleukin-10 (IL-10), thereby fortifying the host’s anti-tumor defenses [14].